Policies on reporting clinical trials and publishing supplements

The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

Nature aging·2026

Clinical approaches to the development of a neuroprotective therapy for PD.

Experimental neurology·2017

Pooled analysis of phase III with entacapone in Parkinson's disease.

Acta neurologica Scandinavica·2014

Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10.

Journal of Huntington's disease·2014

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Neurology·2006

Prevalence of dementia in rural China: impact of age, gender and education.

Acta neurologica Scandinavica·2006

Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes.

Neurology·2026

Glucose and Methionine Metabolism in Disorders of Consciousness After Brain Injury: An Exploratory Longitudinal PET Study.

Neurology·2026

Nongenetic Factors Associated With Onset and Severity of Hereditary Ataxia.

Neurology·2026

Associations Between Cerebral Amyloid Angiopathy, Cognitive Impairment, and Depressive Symptoms.

Neurology·2026

Rate of Autoimmune Diseases in the 10 Years Preceding Myasthenia Gravis Diagnosis: A Nationwide Cohort Study in South Korea.

Neurology·2026

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes.

Neurology·2026

Kidney Transplantation from Hepatitis C-Positive Donors in the Direct-Acting Antiviral Era.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

Policy in implementation science: Considerations for measurement-based care in the Canadian Armed Forces.

Journal of military, veteran and family health·2026

Rigor is not readiness: The PERL framework for evidence-based policy.

Science (New York, N.Y.)·2026

Exploring Australian Health Promotion Practitioners' Awareness, Understanding and Application of Theories of the Policy Process in Health Promotion Practice: A Qualitative Study.

Health promotion perspectives·2026

Policy actors as data integrators: mixing data in tobacco control evaluation and assessment.

Health economics, policy, and law·2026

Factors Determining Sirtuin-1 Target Engagement.

Advanced biology·2026

Related Experiment Videos

Policies on reporting clinical trials and publishing supplements

Related Concept Videos

The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

Clinical approaches to the development of a neuroprotective therapy for PD.

Pooled analysis of phase III with entacapone in Parkinson's disease.

Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10.

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Prevalence of dementia in rural China: impact of age, gender and education.

Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes.

Glucose and Methionine Metabolism in Disorders of Consciousness After Brain Injury: An Exploratory Longitudinal PET Study.

Nongenetic Factors Associated With Onset and Severity of Hereditary Ataxia.

Associations Between Cerebral Amyloid Angiopathy, Cognitive Impairment, and Depressive Symptoms.

Rate of Autoimmune Diseases in the 10 Years Preceding Myasthenia Gravis Diagnosis: A Nationwide Cohort Study in South Korea.

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes.

Kidney Transplantation from Hepatitis C-Positive Donors in the Direct-Acting Antiviral Era.

Policy in implementation science: Considerations for measurement-based care in the Canadian Armed Forces.

Rigor is not readiness: The PERL framework for evidence-based policy.

Exploring Australian Health Promotion Practitioners' Awareness, Understanding and Application of Theories of the Policy Process in Health Promotion Practice: A Qualitative Study.

Policy actors as data integrators: mixing data in tobacco control evaluation and assessment.

Factors Determining Sirtuin-1 Target Engagement.

Related Experiment Videos

Policies on reporting clinical trials and publishing supplements

Related Concept Videos

Related Articles